Skip to Main content Skip to Navigation

Hyaluronic acid nanocapsules for the intracellular delivery of anticancer drugs

Abstract : The main goal of this thesis has been the development of hyaluronic acid nanocapsules (HA NCs) as a multifunctional platform for the encapsulation and delivery of diverse anticancer drugs, such as hydrophobic drugs and hydrophilic biomolecules. The first step was the development of a spontaneous emulsification method, where HA NCs were formulated without the need of organic solvents, heat or high energy input, providing conditions for the incorporation of sensitive biomolecules while decreasing the environmental impact. Another advantage of this system is based on the use of a hydrophobically-modified HA derivative that allowed the preparation of HA NCs by hydrophobic interactions rather than electrostatic forces and thus, reducing the toxicity associated to the addition of a cationic surfactant as a counterion. Once formulated, HANCs had a size around 130 nm and a negative zeta potential about -20 mV. Moreover, these nanocapsules were markedly stable under storage conditions and diluted in human plasma, taking forward this system as a potential carrier for intravenous administration. The versatility of this nanocarrier was confirmed by the incorporation of different molecules : docetaxel, a cytostatic drug, was incorporated into the oil core, whereas anti-gasdermin B, a monoclonal antibody, was entrapped into the polymeric shell. Docetaxel was highly encapsulated, released in a sustained manner and its cytotoxicity in A549 lung cancer cell line was maintained. Finally, anti-gasdermin B was successfully associated to the polymeric shell of HA NCs and its intracellular delivery confirmed by confocal microscopy. Once inside the cell, anti-gasdermin B was able to escape the endosomal compartment and to target the intracellular protein gasdermin B, promoting an important decrease in the migratory and invasive behavior of HCC1954 breast cancer cell line. All these results highlight the potential of self-emulsifying HA NCs as multifunctional systems to transport diverse anticancer drugs, with special emphasisin the intracellular delivery of monoclonal antibodies, an ambitious challenge that could open new avenues to fight cancer.
Document type :
Complete list of metadatas

Cited literature [459 references]  Display  Hide  Download
Contributor : Abes Star :  Contact
Submitted on : Tuesday, May 19, 2020 - 6:01:16 PM
Last modification on : Wednesday, June 17, 2020 - 3:10:43 AM


Version validated by the jury (STAR)


  • HAL Id : tel-02612997, version 2


Ana Cristina Cadete Pires. Hyaluronic acid nanocapsules for the intracellular delivery of anticancer drugs. Pharmacology. Université d'Angers; Universidad de Santiago de Compostela. Facultad de Farmacia, 2016. English. ⟨NNT : 2016ANGE0071⟩. ⟨tel-02612997v2⟩



Record views


Files downloads